
Instil Bio, Inc.
TILHealthcare|Biotechnology|US
$6.83
-0.16 (-2.29%)
Tangible Book / Share
$15.83
Cash / Share
$10.27
Next Earnings Report
Nov 16, 2026
EPS est. -$0.17
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Iovance Reports Updated IOV-LUN-202 Results and Adds Precision TIL Strategy for Second-Line Metastatic Non-Small-Cell Lung Cancer (mNSCLC)
Oct 29, 2026 · GlobeNewsWire
Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Broader Precision Medicine Strategy
Oct 28, 2026 · GlobeNewsWire
Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026
Oct 26, 2026 · GlobeNewsWire
Iovance Presents New Data at ESMO 2026 Demonstrating Deep, Durable Responses with Lifileucel TIL Cell Therapy Plus Pembrolizumab in Frontline Advanced Melanoma
Oct 23, 2026 · GlobeNewsWire
Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026
Oct 19, 2026 · GlobeNewsWire
Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 13, 2026 · GlobeNewsWire
SEC Filings (45)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Jun 11, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 15, 2026 | 8-K | Material event | DocumentIndex |
| Apr 24, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 24, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 24, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 3, 2026 | 8-K | Material event | DocumentIndex |
| Mar 27, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 27, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 27, 2026 | 8-K | Material event | DocumentIndex |
| Feb 9, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 6, 2026 | 8-K | Material event | DocumentIndex |
| Nov 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 13, 2025 | 8-K | Material event | DocumentIndex |
| Aug 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2025 | 8-K | Material event | DocumentIndex |
| Aug 12, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 31, 2025 | 8-K | Material event | DocumentIndex |
| May 28, 2025 | 8-K | Material event | DocumentIndex |
| May 27, 2025 | 8-K | Material event | DocumentIndex |
| May 22, 2025 | 8-K | Material event | DocumentIndex |
| May 15, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2025 | 8-K | Material event | DocumentIndex |
| May 2, 2025 | DEFR14A | DocumentIndex | |
| Apr 14, 2025 | ARS | Annual report to holders | DocumentIndex |
| Apr 14, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 14, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 31, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 31, 2025 | 8-K | Material event | DocumentIndex |
| Mar 4, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Mar 4, 2025 | 10-K | Annual report | DocumentIndex |
| Mar 4, 2025 | 8-K | Material event | DocumentIndex |
| Feb 13, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 14, 2025 | 8-K | Material event | DocumentIndex |
| Dec 23, 2024 | 8-K | Material event | DocumentIndex |
| Nov 21, 2024 | EFFECT | DocumentIndex |